Szczotka-Flynn, Loretta B. O.D., Ph.D.; Debanne, Sara Ph.D.; Benetz, Beth Ann C.R.A.; Wilson, Tawnya O.D.; Brennan, Noel M.Sc.Optom., Ph.D.
University Hospitals Eye Institute (L.B.S.-F., B.A.B.), University Hospitals Case Medical Center, Cleveland, OH; Departments of Ophthalmology and Visual Sciences (L.B.S.-F., B.A.B.), and Epidemiology and Biostatistics (S.D.), Case Western Reserve University, Cleveland, OH; and Johnson & Johnson Vision Care, Inc. (T.W., N.B.), Jacksonville, FL.
Address correspondence to Loretta B. Szczotka-Flynn, O.D., Ph.D., University Hospitals Eye Institute, University Hospitals Case Medical Center, 11100 Euclid Avenue, Lakeside 4126C, Cleveland, OH 44106; e-mail: [email protected]
L. B. Szczotka-Flynn received research support from Alcon Laboratories. The remaining authors have no conflicts of interest to disclose.
Supported by Johnson & Johnson Vision Care, Inc. with indirect support for laboratories and coordination from the Ohio Lions Eye Research Foundation and Research to Prevent Blindness. The clinicalTrials.gov identifier is NCT02328937.